Pulse oximetry non-invasively estimates arterial haemoglobin oxygen saturation from a pulsatile optical signal. A discordant SpO₂ reading requires clinical assessment alongside a review of signal quality and measurement conditions. Checking the sensor may resolve a technical problem; a persistent discrepancy requires clinical assessment and, where appropriate, another method of checking oxygenation.
In a clinic, care home or hospital unit, the doubt often arises in a specific way: the value changes as the patient moves their hand, the signal disappears during a blood pressure measurement, or the number looks reassuring despite a concerning clinical situation. These scenarios call for different decisions. They should not all be grouped under the single label of “pulse oximeter failure”.
This guide separates the checks that can be made during data acquisition from the questions the clinical team must resolve. It also helps procurement and clinical engineering teams specify the monitor, SpO₂ technology and accessories a service needs. The FDA advises interpreting results alongside signs and symptoms and notes that several factors can affect reading accuracy. [1]
What SpO₂ measures and what the number cannot tell you
SpO₂ is the peripheral estimate of oxygen saturation obtained through pulse oximetry. The sensor uses light and the pulsatile component of the signal to estimate the proportion of oxygenated arterial haemoglobin. The number is an estimate, not a direct measurement of oxygen in every tissue. [2]
One distinction is particularly useful in practice: oxygenation and ventilation are not equivalent. Pulse oximetry does not measure CO₂. An SpO₂ reading therefore cannot, on its own, answer a question about CO₂ retention or adequate ventilation. The MHRA makes this point explicitly in its information for healthcare professionals. [3]
The pulse rate displayed alongside saturation should not be treated as an electrocardiographic analysis either. These are measurements derived from the acquired signal, with different functions and limitations. When the clinical question concerns another parameter, the appropriate method is needed to answer it.
Before interpreting a change, establish what is being compared: the same patient, the time, the measurement site, the sensor and the conditions. A trend may provide information; a series of numbers obtained under unknown conditions is harder to explain.
A discordant SpO₂ reading starts with patient assessment
If there is difficulty breathing, deterioration or other concerning signs, checking the sensor must not delay the response required by the facility’s protocol. An apparently reassuring number must not be used on its own to rule out a problem. The FDA warns that some people with low oxygen levels may not show all the expected symptoms. [1]
The purpose of reviewing a reading is to establish whether the measurement reasonably reflects the condition being assessed. Clinical escalation remains an option from the outset: request an assessment or activate the appropriate care pathway. There is no requirement to finish a technical checklist before raising a concern.
Consider a hypothetical example. During a ward round, an unexpected reading appears as the patient moves their hand while adjusting their position. If their clinical condition allows the acquisition to be checked, reviewing sensor placement and observing the signal makes sense. If the patient deteriorates, the task is no longer to “get a stable reading”: the team must address the situation and obtain the necessary information through the appropriate methods.
Review the signal without overinterpreting it
A displayed number does not, by itself, show that acquisition is adequate. Depending on the device and configuration, a plethysmographic waveform, pulse amplitude indicator or technical messages may help assess the signal. Their meaning must be understood from the manual for the specific device. [10]
A clean waveform is not proof of clinical accuracy either. Signal information helps identify acquisition difficulties, but it does not remove all the limitations of pulse oximetry. Two separate questions are therefore useful: “Is a usable signal being acquired?” and “Is this measurement sufficient for the clinical decision?” The second requires context.
| Observed situation | What to review | Limit of the check |
|---|---|---|
| Reading varies with movement | Stability of the measurement site and sensor placement | Correcting movement does not automatically explain a clinical discrepancy |
| Weak signal in a cold or poorly perfused limb | Site conditions and alternatives permitted by the sensor instructions | A weak signal must not be interpreted as normal saturation or as a diagnosis |
| Reading is lost when a blood pressure cuff inflates | Simultaneous use of the cuff and sensor on the same limb | The Spot Vital Signs 4400 manual warns of loss of pulsatile flow and inaccurate readings in this situation |
| Nail polish, ambient light or incorrect sensor placement | Optical interference and positioning according to the instructions | The result is not corrected by adding or subtracting a percentage |
| Stable reading that does not match the patient’s condition | Clinical assessment and the need for another check | Repeating the same measurement does not necessarily resolve its limitations |
Optical and perfusion factors are described in the MHRA guidance; the cuff warning comes from the Spot Vital Signs 4400 manual. The table suggests how to organise the review without assigning a definitive cause to each scenario. [3, 5]
Pigmentation and other limitations that repositioning cannot remove
Skin pigmentation is one of the limitations to consider when interpreting pulse oximetry. The FDA acknowledges performance differences between people with lighter and darker skin pigmentation and maintains specific information on the issue. This does not mean that every model, sensor and set of conditions produces the same error. [1, 6]
The practical consequence is to pay attention to discordance. The sources reviewed provide no universal correction that permits SpO₂ to be adjusted manually according to skin tone. A fixed error margin should not be assigned to a person based on appearance.
Some clinical questions also fall outside the capabilities of conventional pulse oximetry. The WHO training manual explains, for example, that carbon monoxide exposure can produce a misleadingly high reading. Clinical suspicion requires an appropriate assessment and measurement technique; changing fingers does not turn pulse oximetry into a test for that exposure. [2]
These limitations should be included in staff training. Instructions that focus only on applying a clip and waiting for a number leave out the decisive step: recognising when the measurement is insufficient. Training should include examples of a poor signal and examples of an apparently good signal that conflicts with the clinical picture, because they require different responses.
Choosing pulse oximetry equipment requires a defined use
“Includes SpO₂” is not a sufficient purchasing specification. The service needs to establish whether it will take spot measurements, which patients it will assess and which accessories it will use. It must then check the proposed configuration, its limits of use and the documentation supplied with the unit.
The Welch Allyn Connex Spot Monitor, listed in EQUIMED’s catalogue, supports Masimo, Nellcor or Nonin SpO₂ technology depending on configuration. This does not mean that a single unit has all three technologies or that their sensors are interchangeable. The product family name does not replace identification of the installed module. [7, 8]
For the Spot Vital Signs 4400, the manufacturer’s documentation lists a Nonin SpO₂ option. Its instructions describe spot checks or single measurements initiated by the operator and exclude unattended monitoring and patient transport. A vital signs display should not be taken as a promise of continuous monitoring. [5, 9]
| Service decision | Evidence to request | What it establishes |
|---|---|---|
| Spot measurements or monitoring | Intended use, contraindications, available profiles and supervision requirements | Whether the equipment suits the proposed clinical workflow |
| SpO₂ technology | Configuration reference and installed module | Which documentation and sensor family apply |
| Patient population and measurement site | Sensor instructions and accessories approved for the unit | Whether the sensor is suitable for the intended patient and site |
| Signal review | Manual for the installed version and available indicators | What the operator can review and what each indicator means |
| Preserving context | Recording functions and the facility’s procedure | How the patient, time, conditions and incidents will be linked |
The table organises selection criteria. The sources reviewed do not support a ranking of accuracy across brands.
The guide to medical equipment for primary care places the monitor within the consultation room. Here, the decision is limited to its use for SpO₂ and the accompanying accessories. If the clinical need is different, the purchasing specification must change accordingly.
A connector that fits does not establish measurement compatibility
Before ordering a replacement sensor, keep a record of the exact monitor reference, SpO₂ technology and approved accessory reference. The check must extend to the sensor instructions: patient population, site, placement and conditions of use.
It is not enough for the cable to fit. The Connex Spot Monitor manual requires approved accessories and refers users to the sensor manufacturer’s instructions. [4] An internal list of verified references avoids ordering based on visual similarity or an incomplete product description.
Sensor replacement should also be distinguished from a suspected technical fault in the monitor. Repeatedly changing accessories without recording what has been tried makes it harder for technical support to reconstruct the problem. Traceability begins with a precise description of what was observed.
How to organise checks without repeating until the expected number appears
The following sequence is a working framework to adapt to the facility’s protocol. It does not prescribe treatment or replace the instructions for use.
- Assess the patient and establish priority. Relate the measurement to the patient. If there is deterioration or clinical concern, activate the appropriate response without waiting to finish the technical review.
- Identify the measurement. Confirm the patient, time, site, sensor and device. Check that the accessory is approved for that unit and use.
- Review acquisition. Check placement, movement, perfusion, interference and messages against the applicable manuals. Avoid actions that are not described in the instructions.
- Reassess with context. If repeating the measurement is clinically appropriate, document which condition has been corrected. A new reading allows comparison; it does not erase the initial observation.
- Resolve the discrepancy or escalate it. If it persists, request assessment and any further check the clinical team considers appropriate. If there is a technical fault, follow the facility’s reporting procedure and make a suitable alternative resource available.
A common error is to keep only the last value because it seems more plausible. This hides the sequence: what prompted the repeat, what changed and whether the patient’s condition changed too. The record should make the decision understandable, even when the first acquisition could not be considered valid.
Another error is to use a functional tester as proof of accuracy in all patients. The Connex Spot Monitor manual distinguishes functional testing from assessment of the clinical accuracy of the pulse oximeter and sensor. [4] These are different technical questions requiring different evidence.
The record should explain why a reading was accepted, repeated or questioned
An isolated value leaves questions unanswered. To help the next person interpret it, the service’s procedure can include the time, measurement site, relevant conditions, observed acquisition quality and action taken. If the patient was receiving oxygen, that context should also be preserved according to the facility’s recording system.
Not all these details need to be entered on the monitor screen. Check which fields the configuration supports and where the remaining information is documented. Transfer to the electronic health record, where available and implemented, does not automatically turn a doubtful acquisition into a clinically validated measurement.
The allocation below is an organisational proposal that each facility should adapt to its responsibilities and procedures. Its purpose is to prevent a concern from falling between two services without anyone responsible for following it through.
| Responsibility | What must be addressed | Useful evidence for follow-up |
|---|---|---|
| Professional taking the measurement | Identification, acquisition according to the manual and communication of the discrepancy | Reading, time, conditions, messages and checks performed |
| Responsible clinical team | Interpretation, priority of care and need for another method | Documented assessment and decision |
| Clinical engineering or technical support | Suspected fault, authorised inspection and return to use | Unit and accessory identification, incident and technical findings |
| Procurement and equipment manager | Configuration and availability of suitable accessories | Approved references, documentation and replacement procedure |
The article on ambulatory blood pressure monitoring explores the importance of conditions and recording for a different measurement. In pulse oximetry, the same principle means keeping the number connected to how it was acquired and to the clinical situation. Blood pressure validity criteria should not be transferred to SpO₂.
Frequently asked questions about pulse oximetry
What should be checked when pulse oximetry does not match the patient’s condition?
First, assess the patient and the priority of care. If the situation allows technical checks, review the sensor, placement, conditions and signal quality according to the applicable instructions. A persistent discrepancy requires clinical assessment and, where appropriate, another check; it is not resolved by choosing the most reassuring number.
Does an apparently normal SpO₂ rule out a ventilation problem?
No. Pulse oximetry does not measure CO₂ and cannot, on its own, establish whether ventilation is adequate. The reading must be considered alongside clinical assessment and the methods appropriate to the question being addressed. [3]
Can a blood pressure cuff affect the SpO₂ reading?
Yes. The Spot Vital Signs 4400 manual warns that simultaneous use of a finger sensor and blood pressure cuff on the same limb can interrupt pulsatile blood flow and cause loss of the reading or inaccurate values. Follow the instructions for the device and sensor. [5]
Should SpO₂ be corrected by a percentage based on skin pigmentation?
No universal correction should be invented or applied. The FDA acknowledges performance differences related to pigmentation. The response is to consider this limitation, pay attention to clinical discordance and decide whether another check is needed, without assigning a fixed error to each person. [1, 6]
Do all Connex Spot Monitor units use the same SpO₂ sensors?
No. Connex Spot Monitor supports different SpO₂ technologies depending on configuration. The installed module and the manufacturer’s instructions determine which accessories are approved. Verify the sensor reference for the specific unit before using it or ordering a replacement. [4, 7, 8]
Can Spot Vital Signs 4400 be used for unattended monitoring?
No. Its instructions for use describe spot checks or single measurements initiated by the operator and exclude unattended monitoring. They also exclude patient transport. Equipment selection must match the intended use and clinical procedure. [5]
Define the configuration before introducing the monitor into the service
If you are specifying equipment for SpO₂ measurements, the next step is to bring together the intended clinical use, patient population and required sensor references. You can contact EQUIMED to discuss the configuration and documentation for the device you are considering. The decision should be based on specific references, limits of use and an acquisition and recording procedure the service can apply.
Sources
The instructions for use must match the model, configuration and version of the installed equipment.
- FDA, Pulse Oximeter Basics. Clinical interpretation, factors affecting accuracy and pigmentation.
- WHO, Pulse Oximetry Training Manual. Optical principles and limitations in carbon monoxide exposure. Training material published in 2011; not used here to prescribe treatment.
- MHRA, The use and regulation of pulse oximeters. Published on 26 March 2021. Used for measurement limitations; UK regulatory provisions are not applied to Spain.
- Welch Allyn, Connex Spot Monitor, Directions for use. DIR 80019224, revision N, April 2017. Documentary reference for general warnings; not presented as the current manual for every unit. Consult the revision applicable to the installed device.
- Welch Allyn, Spot Vital Signs 4400, Spanish instructions for use. 80026414, version D, October 2021, software 1.X. Intended use, contraindications and the cuff and sensor warning.
- FDA, Pulse Oximeters. Limitations and work on performance across skin pigmentations.
- EQUIMED, Connex Spot Monitor. Catalogue listing and SpO₂ configurations.
- Hillrom/Baxter, Welch Allyn Connex Spot Monitor. SpO₂ technologies. Australian product page; commercial references and availability in Spain require confirmation.
- Hillrom/Baxter, Spot Vital Signs 4400. Nonin SpO₂ option. Canadian product page; the commercial configuration in Spain requires confirmation.
- Welch Allyn, Connex Spot Monitor, Directions for use, software 1.5X. 80030357, version A, September 2025. Australian edition, software 1.5X. Describes signal indicators according to configuration; consult the revision applicable to the installed unit.